# Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study

**Authors:** Ferdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, Melissa Sorosina, Alen Zollo, Fredrik Piehl, Tomas Olsson, Pernilla Stridh, Maja Jagodic, Bernhard Hemmer, Christiane Gasperi, Adil Harroud, Klementy Shchetynsky, Alessandra Mingione, Elisabetta Mascia, Kaalindi Misra, Antonino Giordano, Maria Laura Terzi Mazzieri, Alberto Priori, Janna Saarela, Ingrid Kockum, Massimo Filippi, Federica Esposito, Filippo Martinelli Boneschi

PMC · DOI: 10.1007/s00415-025-13108-x · Journal of Neurology · 2025-05-27

## Full-text entities

- **Diseases:** multiple sclerosis (MESH:D009103)
- **Chemicals:** Natalizumab (MESH:D000069442)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12116983/full.md

---
Source: https://tomesphere.com/paper/PMC12116983